Basiran

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

• Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Basiran October 9, 2026

NORMAN, OK – In a significant leap forward for cancer research, scientists at the University of Oklahoma...

Read More Read more about Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Advancing the Frontier of Oncology: Taylor & Francis Calls for Submissions on Biliary Cancer Innovation

• Clinical Oncology Education

Advancing the Frontier of Oncology: Taylor & Francis Calls for Submissions on Biliary Cancer Innovation

Basiran October 9, 2026

In the high-stakes world of gastrointestinal oncology, few diagnoses carry the clinical complexity and urgency of biliary...

Read More Read more about Advancing the Frontier of Oncology: Taylor & Francis Calls for Submissions on Biliary Cancer Innovation

Bridging the Gap: Tameron Harvell’s Mission to Democratize Precision Oncology

• Metastatic Breast Cancer Research

Bridging the Gap: Tameron Harvell’s Mission to Democratize Precision Oncology

Basiran October 9, 2026

In the rapidly shifting landscape of modern medicine, the transition from reactive treatment to proactive, precision-based care...

Read More Read more about Bridging the Gap: Tameron Harvell’s Mission to Democratize Precision Oncology

Bridging the Gap: Canadians Demand National Standards for Coordinated Breast Cancer Care

• Patient Advocacy and Support

Bridging the Gap: Canadians Demand National Standards for Coordinated Breast Cancer Care

Basiran October 8, 2026

TORONTO — In a landmark shift of public opinion that underscores a growing frustration with the fragmentation...

Read More Read more about Bridging the Gap: Canadians Demand National Standards for Coordinated Breast Cancer Care

ArriVent’s Firmonertinib Falls Short in Key NSCLC Trial, Sending Stock Plummeting Amidst Competitive Landscape

• Medical Research and Clinical Trials

ArriVent’s Firmonertinib Falls Short in Key NSCLC Trial, Sending Stock Plummeting Amidst Competitive Landscape

Basiran October 8, 2026

Disappointing Phase III results for ArriVent BioPharma’s lead candidate, firmonertinib, in the treatment of non-small cell lung...

Read More Read more about ArriVent’s Firmonertinib Falls Short in Key NSCLC Trial, Sending Stock Plummeting Amidst Competitive Landscape

Zenflow Secures $52M Series D Funding to Scale Commercialization of Breakthrough BPH Spring Implant

• Treatment Innovations

Zenflow Secures $52M Series D Funding to Scale Commercialization of Breakthrough BPH Spring Implant

Basiran October 8, 2026

In a significant move that promises to reshape the landscape of urological care, Zenflow, a California-based medical...

Read More Read more about Zenflow Secures $52M Series D Funding to Scale Commercialization of Breakthrough BPH Spring Implant

Bridging the Gap: Tameron Harvell and the Future of Precision Oncology

• Metastatic Breast Cancer Research

Bridging the Gap: Tameron Harvell and the Future of Precision Oncology

Basiran October 8, 2026

In the rapidly shifting landscape of modern medicine, the intersection of patient advocacy, clinical expertise, and cutting-edge...

Read More Read more about Bridging the Gap: Tameron Harvell and the Future of Precision Oncology

Navigating the Post-Treatment Journey: Breast Cancer Canada’s October Education Series

• Global Breast Cancer Awareness

Navigating the Post-Treatment Journey: Breast Cancer Canada’s October Education Series

Basiran October 7, 2026

As the landscape of oncology continues to evolve, the transition from active cancer treatment to long-term survivorship...

Read More Read more about Navigating the Post-Treatment Journey: Breast Cancer Canada’s October Education Series

The Architect of Oncology Data: A Comprehensive Profile of Lori Swain’s Transformative Leadership

• Patient Advocacy and Support

The Architect of Oncology Data: A Comprehensive Profile of Lori Swain’s Transformative Leadership

Basiran October 7, 2026

Main Facts: A Quarter-Century of Impact in Cancer Surveillance Lori Swain, MS, stands as one of the...

Read More Read more about The Architect of Oncology Data: A Comprehensive Profile of Lori Swain’s Transformative Leadership

Forbion’s $2.6 Billion Windfall: A Rare Lifeline for Europe’s Cooling Biotech Sector

• Chemotherapy and Targeted Therapy

Forbion’s $2.6 Billion Windfall: A Rare Lifeline for Europe’s Cooling Biotech Sector

Basiran October 7, 2026

By Gwendolyn Wu Published October 6, 2026 In a significant display of resilience for the European life...

Read More Read more about Forbion’s $2.6 Billion Windfall: A Rare Lifeline for Europe’s Cooling Biotech Sector